Who founded Click Therapeutics?

Click Therapeutics was founded by David B. Klein in 2012.

Who are Click Therapeutics's investors?

Click Therapeutics's investors include Accelmed Partners, H.I.G. Capital, H.I.G. HealthBridge Partners, Health Catalyst Capital, Hikma Ventures, Revelation Partners, Sanofi Ventures, Supernode Ventures and 4 more.

How much funding has Click Therapeutics raised?

Click Therapeutics has disclosed $286.7M raised across 12 rounds.

Where is Click Therapeutics headquartered?

Click Therapeutics is headquartered in New York, US.

Click Therapeutics

New York, US · Founded 2012 · Delaware corporation · 106 employees on LinkedIn · 14 known investors

Find your way into Click Therapeutics

Paths you didn't know you had: your email and LinkedIn already hold routes to the Click Therapeutics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Click Therapeutics develops, validates, and commercializes software-based prescription medical treatments, including software-enhanced drug products that combine digital therapeutics with pharmacotherapy. It targets diseases through a platform-based approach applying neuroscience and neuromodulatory mechanisms for patients with unmet medical needs.

Biotech Digital Health Healthtech Medical Devices

Founders & leadership

Click Therapeutics was founded in 2012 by David B. Klein.

David B. Klein Founder & CEODavid Klein is founder and CEO of Click Therapeutics, which develops software-based prescription medical treatments including digital therapeutics combined with pharmacotherapy. He previously served as Managing Director at Opus Point Partners, where he helped create and finance multiple science companies, and holds a bachelor's degree from Brandeis University.

Randall Stanicky Chief Financial OfficerRandall Stanicky is Chief Financial Officer at Click Therapeutics and brings two decades of Wall Street experience, including senior analyst roles at Goldman Sachs and RBC Capital Markets focused on specialty pharmaceuticals, along with board experience across nonprofit, public and private organizations.

Anthony CostelloNamed on SEC filing

Bruce RobertsonNamed on SEC filing

Douglas LangaNamed on SEC filing

Board

Alex ZissonBoard directorManaging Director at H.I.G. HealthBridge Partners

Lee Shapiro Board Member2021–2025Lee Shapiro is a Director at Click Therapeutics with over 30 years of experience building companies; he served as an officer of Allscripts Healthcare Solutions for more than 12 years, overseeing strategy, international operations, business development, government relations, and analytics, and was an early investor, board member, and CFO of Livongo Health. He is a partner at 7wireVentures, which invests in early- and growth-stage companies.

Cris De Luca Board MemberCris De Luca is a Partner at Sanofi Ventures leading the firm's AI and Digital Health investment portfolio since 2020. He previously served as Global Head of Digital Innovation at Johnson & Johnson, worked in emerging technology programs at Novartis, and co-founded Ultra Light Startups, an early-stage startup accelerator that supported over 700 companies.

Maria Forero Board directorSenior Advisor at Accelmed Partners

David FriedmanBoard director

Lezrene CunninghamBoard director

Jeffrey BerkowitzBoard director

Investors · 14

Accelmed Partnerslisted by Accelmed PartnersMiami

How we know: Accelmed Partners's portfolio page · board seat on SEC Form D · bhbusiness.com · Not right? Tell us

H.I.G. Capitallisted by H.I.G. CapitalMiami

How we know: hig.com · Not right? Tell us

H.I.G. HealthBridge Partnerslisted by H.I.G. HealthBridge PartnersMiami · $5M – $40M

How we know: H.I.G. HealthBridge Partners's portfolio page · Not right? Tell us

Health Catalyst Capitallisted by Health Catalyst CapitalNew York

How we know: Health Catalyst Capital's portfolio page · Not right? Tell us

Hikma Ventureslisted by Hikma VenturesLondon · $5M

How we know: Hikma Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Revelation Partnerslisted by Revelation PartnersSausalito · $5M – $50M

How we know: Revelation Partners's portfolio page · Not right? Tell us

Sanofi Ventureslisted by Sanofi VenturesCambridge · $5Mvia Cris De Luca · board

How we know: Sanofi Ventures's portfolio page · a partner's Signal profile · board seat on SEC Form D · bhbusiness.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Supernode Ventureslisted by Supernode VenturesNew York · $500K – $1.3M

How we know: Supernode Ventures's portfolio page · the VCSheet dataset · Not right? Tell us

7wire VenturesinferredChicago · $100K – $5Mvia Lee Shapiro · board

How we know: board seat on SEC Form D · Not right? Tell us

Boehringer Ingelheim Venture FundreportedIngelheim am Rhein · $16.2M

How we know: funding news · Not right? Tell us

H.I.G. BioHealth Partnersreported

How we know: bhbusiness.com · Not right? Tell us

Omega FundsreportedBoston

How we know: a partner's Signal profile · Not right? Tell us

Also in the syndicate · 2

Boehringer IngelheimDassault Systèmes

Funding

SEC filings, press & company announcements

$286.7M disclosed across 12 rounds · 2014–2026

$50MraisedApr 2026 · 2 sources
Source ↗
$50MSeries DApr 2026 · 3 sources
Boehringer Ingelheim
Source ↗

▶$50MraisedOct 2026 · 1 investors · Other Health Care

Rule 506(b)